Viasat (VSAT), Safran Team Up to Boost Rocket Telemetry System
https://www.zacks.com/stock/news/2200606/viasat-vsat-safran-team-up-to-boost-rocket-telemetry-system?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2200606
Dec 20, 2023 - By enhancing the InRange rocket telemetry system, Viasat (VSAT) is seeking to boost commercial prospects in the market of launch operators and spaceports.
0
Tyler (TYL) & NY Police Team Up for Firearm Background Check
https://www.zacks.com/stock/news/2201239/tyler-tyl-ny-police-team-up-for-firearm-background-check?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2201239
Dec 21, 2023 - Tyler (TYL) implements State Firearm Point of Contact Background Check solution for the New York State Police, aligning with the 2022 gun-safety legislation in New York.
0
Immunovant (IMVT) Up on Upbeat Initial Batoclimab GD Study Data
https://www.zacks.com/stock/news/2201100/immunovant-imvt-up-on-upbeat-initial-batoclimab-gd-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201100
Dec 21, 2023 - Immunovant (IMVT) announces positive initial data from the mid-stage study of batoclimab in patients with Graves' disease. The stock gains 12% in the after-market hours, following the news.
0
MillerKnoll (MLKN) Q2 Earnings Beat Estimates, Up Y/Y, View Up
https://www.zacks.com/stock/news/2201132/millerknoll-mlkn-q2-earnings-beat-estimates-up-y-y-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2201132
Dec 21, 2023 - MillerKnoll (MLKN) second-quarter fiscal 2024 results benefit from strategic inventory management, improved gross margins and pricing initiatives.
0
Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
https://www.zacks.com/stock/news/2201158/biotech-stock-roundup-cgen-up-on-gild-deal-mrna-gains-on-study-data-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2201158
Dec 21, 2023 - Compugen (CGEN) and Moderna (MRNA) are in the news on collaboration and study updates, respectively.
0
Pick These Top-Ranked Stocks to Deck Up Your Christmas Tree
https://www.zacks.com/stock/news/2201525/pick-these-top-ranked-stocks-to-deck-up-your-christmas-tree?cid=CS-ZC-FT-analyst_blog|investment_ideas-2201525
Dec 22, 2023 - We have crafted a tree with the most flourishing stocks of 2023 and the ones that are poised to soar in 2024.
0
Putting Up the ETF Tree of Wealth to Brighten 2024
https://www.zacks.com/stock/news/2201602/putting-up-the-etf-tree-of-wealth-to-brighten-2024?cid=CS-ZC-FT-etf_news_and_commentary-2201602
Dec 22, 2023 - Given the significance in this season of joy, we have built a tree with the most verdant ETFs of 2023 that could stand tall in 2024.
0
HNI (HNI) Is Up 1.64% in One Week: What You Should Know
https://www.zacks.com/stock/news/2201723/hni-hni-is-up-1-64-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2201723
Dec 22, 2023 - Does HNI (HNI) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
https://www.zacks.com/stock/news/2202251/cidara-cdtx-up-on-ec-nod-for-rezzayo-in-invasive-candidiasis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202251
Dec 26, 2023 - Cidara's (CDTX) Rezzayo (rezafungin acetate) gets approval from the European Commission for the treatment of invasive candidiasis in adults. The stock rises 11.1%.
0
Tuya Inc. Sponsored ADR (TUYA) Is Up 0.99% in One Week: What You Should Know
https://www.zacks.com/stock/news/2202773/tuya-inc-sponsored-adr-tuya-is-up-0-99-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2202773
Dec 27, 2023 - Does Tuya Inc. Sponsored ADR (TUYA) have what it takes to be a top stock pick for momentum investors? Let's find out.
0